Icade S.A., the minority shareholders of Icade Santé and Primonial REIM, announced the signing of an exclusivity agreement regarding the liquidity of Icade’s stake in Icade Santé and the launch of a sale process of Icade Healthcare Europe’s (IHE) asset portfolio for an estimated valuation of €2.6 billion.
With the completion of this liquidity event, which is one of the group's priorities for 2023, Icade will crystallize the value of the Healthcare Property Investment Division and externalize the unrealized capital gains related to its interests in Icade Santé and IHE. (c. €1.2 billion). The cash generated by this transaction will help Icade to fortify its balance sheet and seize potential growth opportunities.
The S&C team advising Icade and Icade Santé on the tax aspects of the transaction includes Gauthier Blanluet, Nicolas de Boynes and Alexis Madec.
Subscribe to stay current on S&C Insights.
Sending an e-mail through this web site does not create an attorney-client relationship. You should not send us any information through this web site that you would want treated confidentially.